Join
Live feed
·
PRReleasevia Quantisnow
Myriad Genetics Inc. logo
SOPHiA GENETICS SA logo

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYGN (Myriad Genetics Inc.), SOPH (SOPHiA GENETICS SA) and more on Quantisnow.